Bayer

News

Bayer has joined the ranks of pharma groups planning major facility investments in the US, with a $2.2bn plan for a new production unit in Ohio.

News

Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.

News

Bayer's fast-growing Kerendia has had its label extended in the US to include chronic kidney disease associated with type 1 diabetes.

News

Bayer chases after Boehringer with an FDA approval for oral HER2 inhibitor Hyrnuo in previously untreated HER2+ lung cancer.

News

Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.

News

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.